Medical News

RSS

Discovery of new target in fight against osteoporosis, periodontitis

Osteoporosis and periodontitis are common diseases whose sufferers must cope with weakness, injury and reduced function as they lose bone more quickly than it is formed. While the mechanism of bone destruction in these diseases is understood, scientists have had less information about how bone formation is impaired.

19 May 2009

Risk perceptions and behaviour towards pandemic control of emerging infectious diseases

With the current outbreak of swine flu, and in the absence of a vaccine or treatment at present, the only way to contain the virus is to get people around the world to take precautionary measures.

19 May 2009

Decoding the human brain

'Nature' journals are synonymous with the very best in research. Earlier this year, an article by University of Leicester bioengineer Professor Rodrigo Quian Quiroga not only appeared in Nature Reviews Neuroscience, but also featured on the magazine cover. In the article, Prof. Quian Quiroga and co-author Dr. Stefano Panzeri discuss new methodologies that are enabling scientists to better understand how our brain processes information.

19 May 2009

HRT-breast cancer risk stays same, regardless of family history

The risk of developing breast cancer due to taking hormone replacement therapy appears to be the same for women with a family history of the disease and without a family history, a University of Rochester Medical Center study concluded.

19 May 2009

UN, WHO heads meet 30 vaccine manufacturers

WHO Director-General Dr Margaret Chan and United Nations Secretary-General Ban Ki-moon met with over 30 vaccine manufacturers from developing and developed countries at WHO headquarters today.

19 May 2009

Intradigm issued RNA interference (RNAi) patent covering potent siRNA sequence

Intradigm Corporation has announced the issuance of United States patent 7,534,878, titled "Composition and Methods of RNAi Therapeutics for Treatment of Cancer and Other Neovascularization Diseases."

19 May 2009

Salmonella’s weakness for sugar predicts its downfall

For the first time UK scientists have shown what the food poisoning bug Salmonella feeds on to survive as it causes infection: glucose.

19 May 2009

New imaging tool helps identify DNA patterns of cancer, genetic disorders

A new tool will help researchers identify the minute changes in DNA patterns that lead to cancer, Huntington's disease and a host of other genetic disorders.

19 May 2009

Would eating five portions of fruit and vegetables a day really benefit everyone?

Eating more healthily might be better for us as individuals, but would it be bad news for farmers? A research project funded by the UK Research Councils’ Rural Economy and Land Use Programme had found that if we all followed government advice to eat five portions of fruit and vegetables a day this could have serious implications for the countryside.

19 May 2009

Drinking too much cola causes muscle problems

Doctors have issued a warning about excessive cola consumption after noticing an increase in the number of patients suffering from muscle problems, according to the June issue of IJCP, the International Journal of Clinical Practice.

19 May 2009

Safe for passengers with lung disease to travel by air

Oxygen levels while flying are substantially less than at ground level. Current guidelines for in-flight oxygen levels are sufficient to support the needs of passengers with non-obstructed lung disease.

19 May 2009

Boston Scientific launches 3rd generation platinum chromium drug-eluting stent

Boston Scientific Corporation today announced the launch of the Platinum chromium Taxus Element Paclitaxel-Eluting Coronary Stent System in select markets worldwide. The Taxus Element Stent features a new Platinum chromium alloy engineered specifically for coronary stent applications and represents the Company's third-generation drug-eluting stent (DES) technology.

19 May 2009

e-mail intervention program helps improve diet and lifestyle

An e-mail intervention program is an effective way to significantly improve diet and physical activity by helping people move more, sit less, and make healthier food choices, according to a Kaiser Permanente Division of Research study in the American Journal of Preventive Medicine.

19 May 2009

Biovail acquires worldwide rights to Tetrabenazine

Biovail Corporation today announced a wholly owned subsidiary has entered into a definitive agreement to acquire worldwide development and commercialization rights to the entire portfolio of tetrabenazine products, including Xenazine/Nitoman (tetrabenazine tablets), and the associated intellectual property rights held by Cambridge Laboratories (Ireland) Ltd and its affiliates.

18 May 2009

A.P. Pharma submits NDA for APF530 in chemo-induced nausea and vomiting

A.P. Pharma, Inc. has announced that it has submitted a New Drug Application (NDA) for its lead product, APF530, to the U.S. Food and Drug Administration (FDA). APF530 is being developed for the prevention of chemotherapy-induced nausea and vomiting (CINV) and is a long-acting formulation of granisetron that utilizes the Company's proprietary Biochronomer drug delivery system.

18 May 2009